Literature DB >> 8387569

IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection.

K N Ward1, J J Gray, M W Fotheringham, M J Sheldon.   

Abstract

Sera from 321 children aged 0-179 weeks and 196 adult blood donors were examined for IgG antibodies to human herpesvirus-6 (HHV-6) using an indirect immunofluorescence test. After birth, antibody prevalence declined to a minimum between 20 and 29 weeks. Thereafter the percentage of individuals with antibody increased up to the age of 60-69 weeks after which the prevalence of antibody in the children remained stable at about 88%; in contrast, the seroprevalence in blood donors was 98%, indicating that some individuals remain susceptible to infection after early childhood but that virtually all are infected by the time they reach adulthood. The HHV-6 antibody titre increased steadily over the first 70 weeks of life and then remained stable up to 179 weeks old at a level significantly higher than that of the adults. Two hundred and eighteen of the 321 sera whose HHV-6 antibody titres were 40 or greater were tested for antibody avidity using a modification of the immunofluorescence test whereby low avidity antibody was eluted with urea. The results show that the age distribution of low avidity antibody closely parallels the known distribution of exanthem subitum and, moreover, that the mean antibody avidity increased with time after primary infection. The method was further validated because well-characterised convalescent sera taken from seven children within 3 weeks of exanthem subitum all contained low avidity antibodies. The data presented in this study indicate that low avidity IgG to HHV-6 may be detected after primary infection and that this should prove useful in diagnosis and for seroepidemiological surveys.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387569     DOI: 10.1002/jmv.1890390209

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  23 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.

Authors:  Katherine N Ward; Hoe Nam Leong; Anton D Thiruchelvam; Claire E Atkinson; Duncan A Clark
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Studies on the antibodies to human herpesvirus type 6 among Hungarian patients with asymptomatic HIV infection.

Authors:  C L Maródi; A Csiszár; B Sierra-Vazquez; D Di Luca; E Barabás; K Nagy; J Ongrádi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

4.  Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.

Authors:  M Hashido; S Inouye; T Kawana
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Reliability of four methods for the diagnosis of acute infection by Epstein-Barr virus.

Authors:  J Gutiérrez; M Rodríguez; C Maroto; G Piédrola
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

6.  Use of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.

Authors:  K N Ward; D J Turner; X C Parada; A D Thiruchelvam
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected].

Authors:  D R Tait; K N Ward; D W Brown; E Miller
Journal:  BMJ       Date:  1996-01-13

8.  Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.

Authors:  K N Ward; N J Andrews; C M Verity; E Miller; E M Ross
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

9.  U20 is responsible for human herpesvirus 6B inhibition of tumor necrosis factor receptor-dependent signaling and apoptosis.

Authors:  Emil Kofod-Olsen; Katrine Ross-Hansen; Mariane Høgsbjerg Schleimann; Dea Kejlberg Jensen; Janni Michelle Lund Møller; Bettina Bundgaard; Jacob Giehm Mikkelsen; Per Höllsberg
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

10.  Seroepidemiology of group C rotavirus infection in England and Wales.

Authors:  Miren Iturriza-Gómara; Ian Clarke; Ulrich Desselberger; David Brown; Daniel Thomas; Jim Gray
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.